Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab

NCT00842699 · clinicaltrials.gov ↗
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Brigham and Women's Hospital

Collaborators